MERIT MEDICAL SYSTEMS INC 8-K

What Happened
Merit Medical Systems, Inc. (MMSI) announced on April 1, 2026 (via an 8-K, Item 7.01) that it completed a merger acquisition of View Point Medical, Inc., making View Point a wholly-owned subsidiary of Merit. Through the transaction Merit acquired View Point’s OneMark® Detection Imaging System, OneMark tissue markers and related assets. Merit included a press release as Exhibit 99.1 to the filing.

Key Details

• Aggregate acquisition consideration (including assumed liabilities) is approximately $140 million.
• $90 million was paid in cash at closing; two deferred payments of $25 million each are scheduled no later than the first and second anniversaries of closing.
• Acquired assets include the OneMark Detection Imaging System and OneMark tissue markers (adds to Merit’s Therapeutic Oncology portfolio).
• The press release referenced non-GAAP financial measures; Merit stated a quantitative reconciliation to GAAP is not available without unreasonable effort.

Why It Matters
This transaction expands Merit’s therapeutic oncology product lineup by adding the OneMark system and tissue markers, potentially broadening its commercial offerings in oncology procedures. For investors, the deal represents an immediate cash outflow of $90M and future obligations totaling $50M (plus assumed liabilities), which may affect near-term liquidity or deployment of capital. The 8-K provides the official disclosure and press release but does not include a detailed GAAP reconciliation for any non-GAAP figures cited.